Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Thomas H. Newton"'
Publikováno v:
Progress in Nuclear Energy. 75:42-48
The Massachusetts Institute of Technology Research Reactor (MITR), with thermal power of 6 MW, is one of the five high-performance research reactors operated in the U.S. An in-house program MCODE-FM (MCNP-ORIGEN Coupled Depletion Program – Fuel Man
Publikováno v:
Nuclear Science and Engineering. 157:264-279
The Massachusetts Institute of Technology (MIT) Reactor II (MITR-II) is a 5-MW research reactor presently fueled with highly enriched uranium (HEU) in uranium-aluminum plate-type elements. A low-en...
Publikováno v:
Nuclear Technology. 139:175-183
A new epithermal neutron irradiation facility, based on a fission converter assembly placed in the thermal column outside the reactor core, has been put into operation at the Massachusetts Institute of Technology Research Reactor (MITR). This facilit
Autor:
B. A. Wilson, P. W. Stahle, B. Sutharshan, P. T. Menadier, Thomas H. Newton, Peter J. Binns, E. J. Fonteneau, Otto K. Harling, Gordon Kohse, John A. Bernard, S. J. Ali, Yakov Ostrovsky, Paul M. Busse, L-W. Hu, W. S. Kiger, Kent J. Riley
Publikováno v:
Nuclear Science and Engineering. 140:223-240
A new type of epithermal neutron irradiation facility for use in neutron capture therapy has been designed, constructed, and put into operation at the Massachusetts Institute of Technology Research...
Publikováno v:
Volume 5: Fuel Cycle, Radioactive Waste Management and Decommissioning; Reactor Physics and Transport Theory; Nuclear Education, Public Acceptance and Related Issues; Instrumentation and Controls; Fusion Engineering.
A neutronic analysis of the Massachusetts Institute of Technology Research Reactor (MITR) is performed using state-of-the-art computational tools: the continuous-energy Monte Carlo code MCNP5 and the point-depletion code ORIGEN2.2. These codes are ex
Publikováno v:
Neutron News. 12:24-26
Neutron capture therapy, usually referred to as boron neutron capture therapy or BNCT, is a promising experimental approach to cancer therapy. BNCT involves the infusion of a non-toxic drug, usually a compound containing B-10, which concentrates pref
Autor:
Paul M. Busse, Jody Kaplan, Otto K. Harling, Kent J. Riley, Thomas H. Newton, X. Q. Lu, Matthew R. Palmer, W. S. Kiger, Irving D. Kaplan, J. Tim Goorley, Cynthia F. Chuang, Robert G. Zamenhof, Gustavo A. Santa Cruz
Publikováno v:
Journal of neuro-oncology. 62(1-2)
A phase I trial was designed to evaluate normal tissue tolerance to neutron capture therapy (NCT); tumor response was also followed as a secondary endpoint. Between July 1996 and May 1999, 24 subjects were entered into a phase I trial evaluating cran
Autor:
Robert G. Zamenhof, J. T. Goorley, Otto K. Harling, Irving D. Kaplan, Cynthia F. Chuang, Kent J. Riley, Paul M. Busse, Thomas H. Newton, Jody Kaplan, G. A. Santa Cruz, W. S. Kiger, Matthew R. Palmer
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 54:241-242
Publikováno v:
Annual Review of Hydrocephalus ISBN: 9783662111604
Neoplasms arising from the midbrain are not uncommon; however, those limited to the tectal region are rare. It is likely that a number of such lesions were not detected in the past, and that such lesions are more common than past experience would ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da197909a14fbf9663c21137fc807adb
https://doi.org/10.1007/978-3-662-11158-1_68
https://doi.org/10.1007/978-3-662-11158-1_68